APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ambulatory Infusion Center

Ambulatory Infusion is the administration of chemotherapy, medications or fluids into the bloodstream through a needle or catheter. Ambulatory Infusion Center helps patients who require infusions of chemotherapy, antibiotics, blood products or other therapies on an outpatient basis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ambulatory Infusion is the administration of chemotherapy, medications or fluids into the bloodstream through a needle or catheter. Ambulatory Infusion Center helps patients who require infusions of chemotherapy, antibiotics, blood products or other therapies on an outpatient basis.

An overpressure event refers to any condition which would cause pressure in a vessel or system to increase beyond the specified design pressure or maximum allowable working pressure (MAWP).

The primary purpose of a pressure Relief Valve is protection of life and property by venting fluid from an overpressurized vessel.

The spring-loaded relief valve is a conventional pressure relief valve that is commonly used in liquid service valves. The valve opens proportionally as the pressure increases to overcome the spring pressure.

Selected research

Market Outlook & Growth Opportunities

Global Ambulatory Infusion Center Market Outlook and Growth Opportunities 2026

Report ID 173896630431 December 2025190 pages

Choose your research edition.

Industry ResearchAmbulatory Infusion Center Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambulatory Infusion Center Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ambulatory Infusion Center Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambulatory Infusion Center Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Ambulatory Infusion Center Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Ambulatory Infusion is the administration of chemotherapy, medications or fluids into the bloodstream through a needle or catheter. Ambulatory Infusion Center helps patients who require infusions of chemotherapy, antibiotics, blood products or other therapies on an outpatient basis.

An overpressure event refers to any condition which would cause pressure in a vessel or system to increase beyond the specified design pressure or maximum allowable working pressure (MAWP).

The primary purpose of a pressure Relief Valve is protection of life and property by venting fluid from an overpressurized vessel.

Read the full market overview

The spring-loaded relief valve is a conventional pressure relief valve that is commonly used in liquid service valves. The valve opens proportionally as the pressure increases to overcome the spring pressure.

Geographically, the global Ambulatory Infusion Center market has been segmented into Americas, Europe, Asia-Pacific and Middle East & Africa. Americas is the dominant market in the global Ambulatory Infusion Center market in terms of value.

The leading players mainly are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, UK HealthCare, CHI Health, Accredo Health, PharMerica, Cleveland Clinic, etc. The market is very fragmented because of numerous hospital outpatient infusion services and clinic services.

This report provides an overview of the global Ambulatory Infusion Center market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ambulatory Infusion Center and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ambulatory Infusion Center revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ambulatory Infusion Center market.

Ambulatory Infusion Center Segment by Company

Option Care Health

Coram CVS

UnitedHealth Group

HCA Healthcare

McLaren

UK HealthCare

CHI Health

Accredo Health

PharMerica

Cleveland Clinic

Ambulatory Infusion Center Segment by Type

Hospital

Clinic

Home Health Agencies

Ambulatory Infusion Center Segment by Application

Cancer

Chronic Disease

Others

Ambulatory Infusion Center Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ambulatory Infusion Center status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ambulatory Infusion Center key companies, revenue, market share, and recent developments.

3. To split the Ambulatory Infusion Center breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ambulatory Infusion Center market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ambulatory Infusion Center significant trends, drivers, influence factors in global and regions.

6. To analyze Ambulatory Infusion Center competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Infusion Center market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Infusion Center and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Infusion Center.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ambulatory Infusion Center industry.

Chapter 3: Detailed analysis of Ambulatory Infusion Center company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ambulatory Infusion Center in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ambulatory Infusion Center in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ambulatory Infusion Center Industry Trends Table 2. Ambulatory Infusion Center Industry Drivers Table 3. Ambulatory Infusion Center Industry Opportunities and Challenges Table 4. Ambulatory Infusion Center Industry Restraints Table 5. Global Ambulatory Infusion Center Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ambulatory Infusion Center Revenue Share by Company (2021-2026) Table 7. Global Ambulatory Infusion Center Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ambulatory Infusion Center Key Company Manufacturing Base & Headquarters Table 9. Global Ambulatory Infusion Center Company, Product Type & Application Table 10. Global Ambulatory Infusion Center Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ambulatory Infusion Center by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hospital Table 15. Significant Companies of Clinic Table 16. Significant Companies of Home Health Agencies Table 17. Global Ambulatory Infusion Center Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Ambulatory Infusion Center Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Ambulatory Infusion Center Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Ambulatory Infusion Center Sales Value Share by Type (2021-2026) Table 21. Global Ambulatory Infusion Center Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Cancer Table 23. Significant Companies of Chronic Disease Table 24. Significant Companies of Others Table 25. Global Ambulatory Infusion Center Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ambulatory Infusion Center Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Ambulatory Infusion Center Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Ambulatory Infusion Center Sales Value Share by Application (2021-2026) Table 29. Global Ambulatory Infusion Center Sales Value Share by Application (2027-2032) Table 30. Global Ambulatory Infusion Center Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ambulatory Infusion Center Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Ambulatory Infusion Center Sales Value Share by Region (2021-2026) Table 33. Global Ambulatory Infusion Center Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Ambulatory Infusion Center Sales Value Share by Region (2027-2032) Table 35. Global Ambulatory Infusion Center Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Ambulatory Infusion Center Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Ambulatory Infusion Center Sales Value Market Share by Country (2021-2026) Table 38. Global Ambulatory Infusion Center Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Ambulatory Infusion Center Sales Value Market Share by Country (2027-2032) Table 40. Option Care Health Company Information Table 41. Option Care Health Business Overview Table 42. Option Care Health Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Option Care Health Ambulatory Infusion Center Product Portfolio Table 44. Option Care Health Recent Development Table 45. Coram CVS Company Information Table 46. Coram CVS Business Overview Table 47. Coram CVS Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Coram CVS Ambulatory Infusion Center Product Portfolio Table 49. Coram CVS Recent Development Table 50. UnitedHealth Group Company Information Table 51. UnitedHealth Group Business Overview Table 52. UnitedHealth Group Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. UnitedHealth Group Ambulatory Infusion Center Product Portfolio Table 54. UnitedHealth Group Recent Development Table 55. HCA Healthcare Company Information Table 56. HCA Healthcare Business Overview Table 57. HCA Healthcare Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. HCA Healthcare Ambulatory Infusion Center Product Portfolio Table 59. HCA Healthcare Recent Development Table 60. McLaren Company Information Table 61. McLaren Business Overview Table 62. McLaren Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. McLaren Ambulatory Infusion Center Product Portfolio Table 64. McLaren Recent Development Table 65. UK HealthCare Company Information Table 66. UK HealthCare Business Overview Table 67. UK HealthCare Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. UK HealthCare Ambulatory Infusion Center Product Portfolio Table 69. UK HealthCare Recent Development Table 70. CHI Health Company Information Table 71. CHI Health Business Overview Table 72. CHI Health Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. CHI Health Ambulatory Infusion Center Product Portfolio Table 74. CHI Health Recent Development Table 75. Accredo Health Company Information Table 76. Accredo Health Business Overview Table 77. Accredo Health Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Accredo Health Ambulatory Infusion Center Product Portfolio Table 79. Accredo Health Recent Development Table 80. PharMerica Company Information Table 81. PharMerica Business Overview Table 82. PharMerica Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. PharMerica Ambulatory Infusion Center Product Portfolio Table 84. PharMerica Recent Development Table 85. Cleveland Clinic Company Information Table 86. Cleveland Clinic Business Overview Table 87. Cleveland Clinic Ambulatory Infusion Center Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Cleveland Clinic Ambulatory Infusion Center Product Portfolio Table 89. Cleveland Clinic Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Ambulatory Infusion Center Product Image Figure 2. Global Ambulatory Infusion Center Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambulatory Infusion Center Market Size (2021-2032) & (US$ Million) Figure 4. Global Ambulatory Infusion Center Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hospital Image Figure 8. Clinic Image Figure 9. Home Health Agencies Image Figure 10. Global Ambulatory Infusion Center Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Ambulatory Infusion Center Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Ambulatory Infusion Center Sales Value Share by Type (2021-2032) Figure 13. Cancer Image Figure 14. Chronic Disease Image Figure 15. Others Image Figure 16. Global Ambulatory Infusion Center Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ambulatory Infusion Center Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Ambulatory Infusion Center Sales Value Share by Application (2021-2032) Figure 19. Global Ambulatory Infusion Center Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Ambulatory Infusion Center Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Ambulatory Infusion Center Sales Value (2021-2032) & (US$ Million) Figure 22. North America Ambulatory Infusion Center Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Ambulatory Infusion Center Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Ambulatory Infusion Center Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Ambulatory Infusion Center Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Ambulatory Infusion Center Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Ambulatory Infusion Center Sales Value (2021-2032) & (US$ Million) Figure 28. South America Ambulatory Infusion Center Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Ambulatory Infusion Center Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Ambulatory Infusion Center Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Ambulatory Infusion Center Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital
  • Clinic
  • Home Health Agencies
Applications
  • Cancer
  • Chronic Disease
  • Others
Companies covered
  • Option Care Health
  • Coram CVS
  • UnitedHealth Group
  • HCA Healthcare
  • McLaren
  • UK HealthCare
  • CHI Health
  • Accredo Health
  • PharMerica
  • Cleveland Clinic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ambulatory Infusion Center Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ambulatory Infusion Center Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ambulatory Infusion Center Market Dynamics
  1. 2.1 Ambulatory Infusion Center Industry Trends
  2. 2.2 Ambulatory Infusion Center Industry Drivers
  3. 2.3 Ambulatory Infusion Center Industry Opportunities and Challenges
  4. 2.4 Ambulatory Infusion Center Industry Restraints
3 Ambulatory Infusion Center Market by Company
  1. 3.1 Global Ambulatory Infusion Center Company Revenue Ranking in 2025
  2. 3.2 Global Ambulatory Infusion Center Revenue by Company (2021-2026)
  3. 3.3 Global Ambulatory Infusion Center Company Ranking (2024-2026)
  4. 3.4 Global Ambulatory Infusion Center Company Manufacturing Base and Headquarters
  5. 3.5 Global Ambulatory Infusion Center Company Product Type and Application
  6. 3.6 Global Ambulatory Infusion Center Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ambulatory Infusion Center Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ambulatory Infusion Center Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ambulatory Infusion Center Market by Type
  1. 4.1 Ambulatory Infusion Center Type Introduction
  2. 4.1.1 Hospital
  3. 4.1.2 Clinic
  4. 4.1.3 Home Health Agencies
  5. 4.2 Global Ambulatory Infusion Center Sales Value by Type
  6. 4.2.1 Global Ambulatory Infusion Center Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ambulatory Infusion Center Sales Value by Type (2021-2032)
  8. 4.2.3 Global Ambulatory Infusion Center Sales Value Share by Type (2021-2032)
5 Ambulatory Infusion Center Market by Application
  1. 5.1 Ambulatory Infusion Center Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Chronic Disease
  4. 5.1.3 Others
  5. 5.2 Global Ambulatory Infusion Center Sales Value by Application
  6. 5.2.1 Global Ambulatory Infusion Center Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ambulatory Infusion Center Sales Value by Application (2021-2032)
  8. 5.2.3 Global Ambulatory Infusion Center Sales Value Share by Application (2021-2032)
6 Ambulatory Infusion Center Regional Value Analysis
  1. 6.1 Global Ambulatory Infusion Center Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ambulatory Infusion Center Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ambulatory Infusion Center Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ambulatory Infusion Center Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ambulatory Infusion Center Sales Value (2021-2032)
  7. 6.3.2 North America Ambulatory Infusion Center Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ambulatory Infusion Center Sales Value (2021-2032)
  10. 6.4.2 Europe Ambulatory Infusion Center Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ambulatory Infusion Center Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ambulatory Infusion Center Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ambulatory Infusion Center Sales Value (2021-2032)
  16. 6.6.2 South America Ambulatory Infusion Center Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ambulatory Infusion Center Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ambulatory Infusion Center Sales Value Share by Country, 2025 VS 2032
7 Ambulatory Infusion Center Country-level Value Analysis
  1. 7.1 Global Ambulatory Infusion Center Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ambulatory Infusion Center Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ambulatory Infusion Center Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ambulatory Infusion Center Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ambulatory Infusion Center Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ambulatory Infusion Center Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ambulatory Infusion Center Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Option Care Health
  2. 8.1.1 Option Care Health Company Information
  3. 8.1.2 Option Care Health Business Overview
  4. 8.1.3 Option Care Health Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Option Care Health Ambulatory Infusion Center Product Portfolio
  6. 8.1.5 Option Care Health Recent Developments
  7. 8.2 Coram CVS
  8. 8.2.1 Coram CVS Company Information
  9. 8.2.2 Coram CVS Business Overview
  10. 8.2.3 Coram CVS Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Coram CVS Ambulatory Infusion Center Product Portfolio
  12. 8.2.5 Coram CVS Recent Developments
  13. 8.3 UnitedHealth Group
  14. 8.3.1 UnitedHealth Group Company Information
  15. 8.3.2 UnitedHealth Group Business Overview
  16. 8.3.3 UnitedHealth Group Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  17. 8.3.4 UnitedHealth Group Ambulatory Infusion Center Product Portfolio
  18. 8.3.5 UnitedHealth Group Recent Developments
  19. 8.4 HCA Healthcare
  20. 8.4.1 HCA Healthcare Company Information
  21. 8.4.2 HCA Healthcare Business Overview
  22. 8.4.3 HCA Healthcare Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HCA Healthcare Ambulatory Infusion Center Product Portfolio
  24. 8.4.5 HCA Healthcare Recent Developments
  25. 8.5 McLaren
  26. 8.5.1 McLaren Company Information
  27. 8.5.2 McLaren Business Overview
  28. 8.5.3 McLaren Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  29. 8.5.4 McLaren Ambulatory Infusion Center Product Portfolio
  30. 8.5.5 McLaren Recent Developments
  31. 8.6 UK HealthCare
  32. 8.6.1 UK HealthCare Company Information
  33. 8.6.2 UK HealthCare Business Overview
  34. 8.6.3 UK HealthCare Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  35. 8.6.4 UK HealthCare Ambulatory Infusion Center Product Portfolio
  36. 8.6.5 UK HealthCare Recent Developments
  37. 8.7 CHI Health
  38. 8.7.1 CHI Health Company Information
  39. 8.7.2 CHI Health Business Overview
  40. 8.7.3 CHI Health Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CHI Health Ambulatory Infusion Center Product Portfolio
  42. 8.7.5 CHI Health Recent Developments
  43. 8.8 Accredo Health
  44. 8.8.1 Accredo Health Company Information
  45. 8.8.2 Accredo Health Business Overview
  46. 8.8.3 Accredo Health Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Accredo Health Ambulatory Infusion Center Product Portfolio
  48. 8.8.5 Accredo Health Recent Developments
  49. 8.9 PharMerica
  50. 8.9.1 PharMerica Company Information
  51. 8.9.2 PharMerica Business Overview
  52. 8.9.3 PharMerica Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PharMerica Ambulatory Infusion Center Product Portfolio
  54. 8.9.5 PharMerica Recent Developments
  55. 8.10 Cleveland Clinic
  56. 8.10.1 Cleveland Clinic Company Information
  57. 8.10.2 Cleveland Clinic Business Overview
  58. 8.10.3 Cleveland Clinic Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cleveland Clinic Ambulatory Infusion Center Product Portfolio
  60. 8.10.5 Cleveland Clinic Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst